VIA Pharmaceuticals (VIAP) Short Interest Ratio & Short Volume

Short interest is the volume of VIA Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 14th, investors have sold 100 shares of VIAP short. Learn More on VIA Pharmaceuticals' current short interest.

VIA Pharmaceuticals saw a increase in short interest in the month of May. As of May 14th, there was short interest totaling 100 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to VIA Pharmaceuticals: Amgen Inc. (1.83%), Gilead Sciences, Inc. (1.46%), argenx SE (3.43%), BioNTech SE (1.03%), Novozymes A/S (0.00%), Biogen Inc. (1.87%), Moderna, Inc. (11.62%), Neurocrine Biosciences, Inc. (4.19%), Bio-Techne Co. (2.22%), Vaxcyte, Inc. (7.77%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon plc ($6.79 billion), Charter Communications, Inc. ($5.98 billion), Analog Devices, Inc. ($5.56 billion), S&P Global Inc. ($5.37 billion), Airbnb, Inc. ($3.72 billion), Nuance Communications, Inc. ($2.87 billion), Snap Inc. ($2.70 billion), Expedia Group, Inc. ($2.27 billion), The Kroger Co. ($2.19 billion), and VMware, Inc. ($2.04 billion). View all of the most shorted stocks.

Short selling VIAP is an investing strategy that aims to generate trading profit from VIA Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for VIA Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VIAP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VIAP, twice per month. The most recent reporting period available is May, 14 2021.